Sheng Han Selected Research

Esophageal Squamous Cell Carcinoma

1/2022

Economic evaluation of tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheng Han Research Topics

Disease

25	Neoplasms (Cancer) 10/2023 - 12/2013
14	Glioma (Gliomas) 10/2023 - 01/2013
9	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 09/2014
9	Glioblastoma (Glioblastoma Multiforme) 03/2022 - 01/2013
4	Coronary Disease (Coronary Heart Disease) 02/2024 - 01/2018
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
3	Infections 03/2024 - 01/2015
3	Inflammation (Inflammations) 03/2023 - 01/2021
3	Carcinogenesis 10/2017 - 02/2015
2	Reperfusion Injury 09/2023 - 01/2023
2	Hypoxia (Hypoxemia) 09/2023 - 01/2014
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2023 - 01/2017
2	Ischemic Stroke 06/2022 - 01/2022
2	Stroke (Strokes) 06/2022 - 12/2021
2	Hypersensitivity (Allergy) 01/2022 - 11/2014
2	Ischemia 01/2021 - 01/2021
2	Asthma (Bronchial Asthma) 04/2018 - 10/2015
2	Burns 04/2004 - 09/2003
1	Essential Hypertension 03/2024
1	Human Influenza (Influenza) 02/2024
1	Fatigue 02/2024
1	Weight Loss (Weight Reduction) 02/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Meningioma (Meningiomas) 11/2022
1	Brain Edema (Cerebral Edema) 11/2022
1	Dyspepsia (Indigestion) 09/2022
1	Pica (Geophagia) 06/2022
1	Angina Pectoris 03/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Vertigo (Positional Vertigo) 01/2022
1	Cerebral Infarction 01/2022
1	Cholangiocarcinoma 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 03/2023 - 09/2003
4	MicroRNAs (MicroRNA)IBA 01/2020 - 10/2015
3	Transcription Factors (Transcription Factor)IBA 10/2023 - 02/2015
3	Temozolomide (Temodar)FDA LinkGeneric 03/2022 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2017
3	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 02/2014
3	Messenger RNA (mRNA)IBA 08/2015 - 01/2013
3	p38 Mitogen-Activated Protein KinasesIBA 12/2014 - 09/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 01/2015
2	Hormones (Hormone)IBA 01/2023 - 01/2017
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 12/2017
2	LithiumIBA 03/2022 - 05/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2021
2	Circular RNAIBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2017
2	danhongIBA 12/2021 - 01/2020
2	InflammasomesIBA 01/2021 - 01/2021
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2018
2	salvianolateIBA 01/2020 - 01/2018
2	alectinibIBA 01/2020 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2018 - 10/2015
2	Phosphotransferases (Kinase)IBA 09/2014 - 09/2003
2	SB 203580IBA 04/2004 - 09/2003
2	salicylhydroxamic acid (SHAM)IBA 04/2004 - 09/2003
1	Antihypertensive Agents (Antihypertensives)IBA 03/2024
1	shexiang tongxinIBA 02/2024
1	Tacrolimus Binding Protein 1A (FKBP12)IBA 10/2023
1	Histones (Histone)IBA 09/2023
1	ethylene ureaIBA 02/2023
1	CopperIBA 02/2023
1	AllantoinIBA 02/2023
1	bailing capsulesIBA 01/2023
1	serum-glucocorticoid regulated kinaseIBA 01/2023
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2023
1	LigandsIBA 01/2023
1	semaglutideIBA 01/2023
1	polyethylene glycol loxenatideIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	ORALIT (ORS)IBA 11/2022
1	B7-H1 AntigenIBA 11/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2022
1	mosaprideIBA 09/2022
1	Butyric Acid (Butanoic Acid)IBA 06/2022
1	MDMB-4en-PINACAIBA 06/2022
1	QilongIBA 06/2022
1	guanxin shutongIBA 03/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	gastrodinIBA 01/2022
1	Ribavirin (Virazole)FDA LinkGeneric 01/2022
1	EdaravoneIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Sulbactam FDA LinkGeneric 01/2022

Therapy/Procedure

12	Therapeutics 01/2023 - 12/2014
6	Drug Therapy (Chemotherapy) 01/2023 - 01/2013
3	Liver Transplantation 09/2023 - 01/2021
2	Length of Stay 03/2024 - 01/2018
2	Warm Ischemia 09/2023 - 01/2023
2	Radiotherapy 11/2022 - 01/2014
1	Immunotherapy 09/2023
1	Aftercare (After-Treatment) 06/2022
1	Injections 01/2022